JND’s CEO Jennifer Keough and her team, including JND Vice President Gretchen Eoff, were designated as the escrow agent and claims processor in the $1 billion settlement in In re Stryker Rejuvenate and ABG II Hip Implant Products Liab. Litig., No. 13-2441 (MDL) (D. Minn.). The settlement was structured to compensate eligible U.S. Patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck hip stems prior to November 3, 2014. As the claims processor, Ms. Keough and her team designed internal procedures to ensure the accurate review of all medical documentation received; designed an interactive website which included online claim filing; and established a toll-free number to allow class members to receive information about the settlement 24 hours a day. Additionally, she oversaw the creation of a deficiency process to ensure claimants were notified of their deficient submission and provided an opportunity to cure. The program also included an auditing procedure designed to detect fraudulent claims and a process for distributing initial and supplemental payments. Approximately 95% of the registered eligible patients enrolled in the settlement program.
We use cookies to help our website function effectively and improve your experience. By continuing to this website, you acknowledge and agree to the manner in which they are used. You can learn more about these cookies by visiting our Privacy and Cookie Policy